
Sign up to save your podcasts
Or
In the second episode of a 4-part podcast series on HCC, the Oncology Brothers, Drs Rahul and Rohit Gosain, host a podcast discussion between Dr Lorenza Rimassa and Prof. Arndt Vogel on 2nd line treatment selection in advanced HCC and when to switch.
The discussion covers a range of topics, including 2nd line options for advanced HCC after progression on 1st line TKIs and IO-based therapies, as well as:
This is the second video podcast episode in a 4-part series. Access the rest of the series here:
Part 1 - The use of IO in unresectable HCC
Part 3 - Intermediate HCC: treatment options and strategies (coming soon)
Part 4 - The evolving role of IO in intermediate HCC (coming soon)
Clinical takeaways
Don't forget to like, subscribe, and check out more episodes for in-depth discussions on oncology topics!
Website: http://www.oncbrothers.com/
X/Twitter: https://twitter.com/oncbrothers
Contact us at [email protected]
4.8
3939 ratings
In the second episode of a 4-part podcast series on HCC, the Oncology Brothers, Drs Rahul and Rohit Gosain, host a podcast discussion between Dr Lorenza Rimassa and Prof. Arndt Vogel on 2nd line treatment selection in advanced HCC and when to switch.
The discussion covers a range of topics, including 2nd line options for advanced HCC after progression on 1st line TKIs and IO-based therapies, as well as:
This is the second video podcast episode in a 4-part series. Access the rest of the series here:
Part 1 - The use of IO in unresectable HCC
Part 3 - Intermediate HCC: treatment options and strategies (coming soon)
Part 4 - The evolving role of IO in intermediate HCC (coming soon)
Clinical takeaways
Don't forget to like, subscribe, and check out more episodes for in-depth discussions on oncology topics!
Website: http://www.oncbrothers.com/
X/Twitter: https://twitter.com/oncbrothers
Contact us at [email protected]
322 Listeners
42 Listeners
111 Listeners
504 Listeners
60 Listeners
1,114 Listeners
182 Listeners
45 Listeners
22 Listeners
360 Listeners
28 Listeners
277 Listeners
60 Listeners
181 Listeners
48 Listeners